Xeris Biopharma (XERS) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.14
-0.12
-0.1
-0.09

Details

Expected EPS
-0.096983
Actual EPS
-0.1
Surprise EPS
-0
Surprise Percent
+3.11%

Description

Xeris Biopharma (XERS) has reported earnings of -0.1 per share for Q3 2024.

0 Comments

Share your thoughts